Skip Navigation

Cardiovascular Research 2004 63(4):582-592; doi:10.1016/j.cardiores.2004.05.001
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes

Giuseppina Bastaa, Ann Marie Schmidtb and Raffaele De Caterina*,a,c

aCNR Institute of Clinical Physiology, Pisa, Italy
bColumbia University, New York, NY, USA
cInstitute of Cardiology and Center for Excellence on Aging, "G. d'Annunzio" University, c/o Ospedale S. Camillo de Lellis, Via Forlanini, 50, I-66100 Chieti, Italy

* Corresponding author. Tel.: +39-0871-41512; fax: +39-0871-402817. Email address: rdecater{at}unich.it

The formation of advanced glycation end products (AGEs) is an important biochemical abnormality that accompanies diabetes mellitus and, likely, inflammation in general. Here we summarize and discuss recent studies indicating that the effects of AGEs on vessel wall homeostasis may account for the rapidly progressive atherosclerosis associated with diabetes mellitus. Driven by hyperglycemia and oxidant stress, AGEs form to a greatly accelerated degree in diabetes. Within the vessel wall, collagen-linked AGEs may "trap" plasma proteins, quench nitric oxide (NO) activity and interact with specific receptors to modulate a large number of cellular properties. On plasma low density lipoproteins (LDL), AGEs initiate oxidative reactions that promote the formation of oxidized LDL. Interaction of AGEs with endothelial cells as well as with other cells accumulating within the atherosclerotic plaque, such as mononuclear phagocytes and smooth muscle cells (SMCs), provides a mechanism to augment vascular dysfunction. Specifically, the interaction of AGEs with vessel wall components increases vascular permeability, the expression of procoagulant activity and the generation of reactive oxygen species (ROS), resulting in increased endothelial expression of endothelial leukocyte adhesion molecules. AGEs potently modulate initiating steps in atherogenesis involving blood-vessel wall interactions, triggering an inflammatory-proliferative process and, furthermore, critically contribute to propagation of inflammation and vascular perturbation in established disease. Thus, a better understanding of the biochemical mechanisms by which AGEs contribute to such processes in the vessel wall could be relevant to devise preventive and therapeutic strategies for diabetic atherosclerosis.

KEYWORDS Advanced glycation end products; Atherosclerosis; Inflammation; Diabetes; Endothelium


Time for primary review 16 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in UrologyHome page
A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?
Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197.
[Abstract] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
A. W. Roberts, A. L. Clark, and K. K. Witte
Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease -- do we need to screen our patients?
Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 153 - 163.
[Abstract] [PDF]


Home page
JDRHome page
P. Bullon, J.M. Morillo, M.C. Ramirez-Tortosa, J.L. Quiles, H.N. Newman, and M. Battino
Metabolic Syndrome and Periodontitis: Is Oxidative Stress a Common Link?
Journal of Dental Research, June 1, 2009; 88(6): 503 - 518.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
R. D. Semba, L. Ferrucci, K. Sun, K. V. Patel, J. M. Guralnik, and L. P. Fried
Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women
Age Ageing, May 1, 2009; 38(3): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. G. Gerrits, A. J. Smit, and H. J. G. Bilo
AGEs, autofluorescence and renal function
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 710 - 713.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
A. M. Sheehy, D. B. Coursin, and R. A. Gabbay
Back to Wilson and Jungner: 10 Good Reasons to Screen for Type 2 Diabetes Mellitus
Mayo Clin. Proc., January 1, 2009; 84(1): 38 - 42.
[Full Text] [PDF]


Home page
DiabetesHome page
P. Jimenez-Quevedo, N. Suzuki, C. Corros, C. Ferrer, D. J. Angiolillo, F. Alfonso, R. Hernandez-Antolin, C. Banuelos, J. Escaned, C. Fernandez, et al.
Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes: A Serial Intravascular Ultrasound Analysis
Diabetes, January 1, 2009; 58(1): 209 - 214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Buetler, T. Henle, and H. Vlassara
The Effects of AGEing on Diet
Am. J. Pathol., January 1, 2009; 174(1): 351 - 353.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
A. Ceriello
Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings
Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 260 - 268.
[Abstract] [PDF]


Home page
DiabetesHome page
N. Mzhavia, S. Yu, S. Ikeda, T. T. Chu, I. Goldberg, and H. M. Dansky
Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
Diabetes, October 1, 2008; 57(10): 2774 - 2783.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Wu, Y. Chen, K. Wilson, A. Chirindel, M. A. Ihnat, Y. Yu, M. E. Boulton, L. I. Szweda, J.-X. Ma, and T. J. Lyons
Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2679 - 2685.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A W van Deutekom, H W M Niessen, C G Schalkwijk, R J Heine, and S Simsek
Increased N{epsilon}-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus
Eur. J. Endocrinol., May 1, 2008; 158(5): 655 - 660.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-J. Choi, H.-S. Lim, J.-S. Choi, S.-Y. Shin, J.-Y. Bae, S.-W. Kang, I.-J. Kang, and Y.-H. Kang
Blockade of Chronic High Glucose-Induced Endothelial Apoptosis by Sasa borealis Bamboo Extract
Experimental Biology and Medicine, May 1, 2008; 233(5): 580 - 591.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Seth, J. Cui, E. To, M. Kwee, and J. Matsubara
Complement-Associated Deposits in the Human Retina
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 743 - 750.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. J. Arsenault, I. Lemieux, J.-P. Despres, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study
Eur. Heart J., November 2, 2007; 28(22): 2770 - 2777.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Scheele, A. R. Nielsen, T. B. Walden, D. A. Sewell, C. P. Fischer, R. J. Brogan, N. Petrovic, O. Larsson, P. A. Tesch, K. Wennmalm, et al.
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
FASEB J, November 1, 2007; 21(13): 3653 - 3665.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
Rheumatology, October 1, 2007; 46(10): 1551 - 1556.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Lewis, N. Stefanovic, J. Pete, A. C. Calkin, S. Giunti, V. Thallas-Bonke, K. A. Jandeleit-Dahm, T. J. Allen, I. Kola, M. E. Cooper, et al.
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Circulation, April 24, 2007; 115(16): 2178 - 2187.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Lapolla, F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Baccarin, B. Laverda, and D. Fedele
Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease
Diabetes Care, March 1, 2007; 30(3): 670 - 676.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. L. Figarola, N. Shanmugam, R. Natarajan, and S. Rahbar
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes
Diabetes, March 1, 2007; 56(3): 647 - 655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Benton, A. Powers, L. Eiselein, R. Fitch, D. Wilson, A. C. Villablanca, and J. C. Rutledge
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R723 - R730.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi, H. Matsui-Hirai, A. Miyazaki-Akita, A. Fukatsu, J. Funami, Q.-F. Ding, S. Kamalanathan, Y. Hattori, L. J. Ignarro, and A. Iguchi
Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes
PNAS, November 7, 2006; 103(45): 17018 - 17023.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Basta, A. M. Sironi, G. Lazzerini, S. Del Turco, E. Buzzigoli, A. Casolaro, A. Natali, E. Ferrannini, and A. Gastaldelli
Circulating Soluble Receptor for Advanced Glycation End Products Is Inversely Associated with Glycemic Control and S100A12 Protein
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4628 - 4634.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Wu, R. Vikramadithyan, S. Yu, C. Pau, Y. Hu, I. J. Goldberg, and H. M. Dansky
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
J. Lipid Res., October 1, 2006; 47(10): 2215 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. M. Hagen and K. M. Sanders
Deglycosylation of the beta1-subunit of the BK channel changes its biophysical properties
Am J Physiol Cell Physiol, October 1, 2006; 291(4): C750 - C756.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Circulation, August 8, 2006; 114(6): 597 - 605.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. W. L. Hartog, A. P. J. de Vries, S. J. L. Bakker, R. Graaff, W. J. van Son, J. J. H. van der Heide, R. O. B. Gans, B. H. R. Wolffenbuttel, P. E. de Jong, and A. J. Smit
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2263 - 2269.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Mahmoudi, J. Mercer, and M. Bennett
DNA damage and repair in atherosclerosis
Cardiovasc Res, July 15, 2006; 71(2): 259 - 268.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch
Diabetes and Advanced Glycoxidation End Products.
Diabetes Care, June 1, 2006; 29(6): 1420 - 1432.
[Full Text] [PDF]


Home page
Vasc MedHome page
L. M Title, E. Ur, K. Giddens, M. J McQueen, and B. A Nassar
Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering
Vascular Medicine, May 1, 2006; 11(2): 101 - 109.
[Abstract] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. P Raghavan, D. W Laight, K. M Shaw, and M. H Cummings
Review: Aspirin and diabetes
The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2): 74 - 82.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. Musicki and A. L. Burnett
eNOS Function and Dysfunction in the Penis
Experimental Biology and Medicine, February 1, 2006; 231(2): 154 - 165.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The Diabetes Control and Complications Trial/Epide
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
N. Engl. J. Med., December 22, 2005; 353(25): 2643 - 2653.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. H. Wu and C. G. Tsai
Infectivity of Hepatic Strain Klebsiella pneumoniae in Diabetic Mice
Experimental Biology and Medicine, November 1, 2005; 230(10): 757 - 761.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
G Davi and A Falco
Oxidant stress, inflammation and atherogenesis
Lupus, September 1, 2005; 14(9): 760 - 764.
[Abstract] [PDF]


Home page
JAMAHome page
E. Ingelsson, J. Sundstrom, J. Arnlov, B. Zethelius, and L. Lind
Insulin Resistance and Risk of Congestive Heart Failure
JAMA, July 20, 2005; 294(3): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Basta, G. Lazzerini, S. Del Turco, G. M. Ratto, A. M. Schmidt, and R. De Caterina
At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products
Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1401 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-a Kim, K. K. Koh, and M. J. Quon
The Union of Vascular and Metabolic Actions of Insulin in Sickness and in Health
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 889 - 891.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. K. Srivastava, K. V. Ramana, and A. Bhatnagar
Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
Endocr. Rev., May 1, 2005; 26(3): 380 - 392.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Falcone, E. Emanuele, A. D'Angelo, M. P. Buzzi, C. Belvito, M. Cuccia, and D. Geroldi
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 1032 - 1037.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.